DUTASTERIDE ZENTIVA LAB 0.5 mg, soft capsule 30 capsules
Active ingredients: DUTASTÉRIDE
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DUTASTERIDE ZENTIVA LAB 0,5 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 30 capsule(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Hypertrophie bénigne de la prostate, en seconde intention, après échec de certains autres traitements :<br>. traitement des symptômes modérés à sévères<br>. prévention des risques associés (rétention aiguë d'urine, chirurgie) ; JOURNAL OFFICIEL ; 22/02/13
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Sept 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64758851CIP73009107CIP133400930091074Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DUTASTÉRIDEcapsule | 0,5 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: DUTASTERIDE 0,5 mg - AVODART 0,5 mg, capsule molle